Repligen Corp [RGEN] stock prices are up 4.18% to $124.38 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RGEN shares have gain 4.07% over the last week, with a monthly amount glided 0.71%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Barclays started tracking the stock with Overweight rating on June 24, 2025, and set its price target to $150. On April 29, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $160 on the stock. Evercore ISI started tracking the stock assigning a In-line rating and suggested a price target of $155 on March 18, 2025. TD Cowen initiated its recommendation with a Buy and recommended $200 as its price target on February 10, 2025. Canaccord Genuity started tracking with a Hold rating for this stock on December 17, 2024, and assigned it a price target of $165. In a note dated November 14, 2024, Wolfe Research initiated an Peer Perform rating.
The stock price of Repligen Corp [RGEN] has been fluctuating between $102.96 and $182.52 over the past year. Currently, Wall Street analysts expect the stock to reach $205 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $124.38 at the most recent close of the market. An investor can expect a potential return of 64.82% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 673.96M for trailing twelve months, representing a surge of 14.81%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 8.59. As well, the Quick Ratio is 7.32, while the Cash Ratio is 5.76. Considering the valuation of this stock, the price to sales ratio is 10.38, the price to book ratio is 3.39.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Sep 10 ’25 when 29111.0 shares were sold. Director, Hunt Anthony completed a deal on Sep 10 ’25 to buy 29111.0 shares. Meanwhile, Director Madaus Martin D bought 1800.0 shares on Aug 08 ’25.
